Clostridium Difficile Infection: Clinical Trials

3 withdrawn. 3 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	3	Withdrawn 3

Follow Clostridium Difficile Infection: new trials by email Literature Review of Clostridium Difficile Infection trials Research Report on Clostridium Difficile Infection

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection fidaxomicin - Clostridium Difficile Infection, Solid Organ Transplant	Phase 4	Withdrawn	University of Colorado, Denver		2018-06-01	2018-08-29
Use of Bismuth Subsalicylate in Clostridium Difficile Colitis Bismuth Subsalicylate, standard antibiotic therapy - Clostridium Difficile Infection	Phase 4	Withdrawn	Bassett Healthcare		2018-03-01	2018-07-19
Fidaxomicin to Prevent Clostridium Difficile Colonization Fidaxomicin, Placebo - Clostridium Difficile Infection	Phase 4	Withdrawn	Washington University School of Medicine		2012-09-01	2014-05-28

Narrower conditions

Clostridium Infections (3)

Broader conditions

Bacterial Infections (3)  ·  Bacterial Infections and Mycoses (3)  ·  Gram-Positive Bacterial Infections (3)  ·  Infections (3)

Interventions

Fidaxomicin (2)  ·  bismuth subsalicylate (1)

Sponsors

Bassett Healthcare (1)  ·  University of Colorado, Denver (1)  ·  Washington University School of Medicine (1)

Countries

United States (2)

Top investigators

Abdulhadi Quadri, MD (1)  ·  Kelly E Schoeppler, PharmD (1)

NIH funding

U54CK000162 (1)